Unique medicinal properties of withania somnifera: Phytochemical constituents and protein component

Current Pharmaceutical Design

Volumn 22, Issue 5, 2016, Pages 535-540

  Dar, Parvaiz A ^a   Singh, Laishram R ^b   Kamal, Mohammad A ^c   Dar, Tanveer A ^a  

^a UNIVERSITY OF KASHMIR   (India)

^b UNIVERSITY OF DELHI   (India)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Anti microbial; Glycoprotein; Immunomodulation; Neurodegenerative disorders; Withaferin; Withanolides

Indexed keywords

ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; BR 16A; GLYCOPROTEIN; IMMUNOMODULATING AGENT; LECTIN; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUROPROTECTIVE AGENT; PHOSPHOLIPASE INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; WITHAFERIN A; WITHANIA SOMNIFERA EXTRACT; WITHANOLIDE; WITHANOLIDE D; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; PLANT PROTEIN;

APOPTOSIS; ASPERGILLUS NIGER; BACILLUS CEREUS; BACILLUS SUBTILIS; BACTERICIDAL ACTIVITY; CANDIDA ALBICANS; CITROBACTER FREUNDII; CYTOTOXICITY; DRUG ACTIVITY; ESCHERICHIA COLI INFECTION; EXCITOTOXICITY; FUNGICIDAL ACTIVITY; GROWTH INHIBITION; HUMAN; IMMUNOMODULATION; KLEBSIELLA PNEUMONIAE; LISTERIOSIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROCOCCUS LUTEUS; MINIMUM INHIBITORY CONCENTRATION; NEISSERIA GONORRHOEAE; NEUROPROTECTION; NONHUMAN; PERTUSSIS; PHYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PSEUDOMONAS AERUGINOSA; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; STAPHYLOCOCCUS AUREUS; STRESS RELIEVING ACTIVITY; TRICHOPHYTON MENTAGROPHYTES; TYPHOID FEVER; WITHANIA SOMNIFERA; ANXIETY; CHEMISTRY; DRUG EFFECTS; ISOLATION AND PURIFICATION; METABOLISM; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHYTOTHERAPY; WITHANIA;

ANTI-INFECTIVE AGENTS; ANXIETY; HUMANS; IMMUNOMODULATION; NEOPLASMS; NEURODEGENERATIVE DISEASES; PHYTOCHEMICALS; PHYTOTHERAPY; PLANT EXTRACTS; PLANT PROTEINS; WITHANIA;

EID: 84958259294     PISSN: 13816128     EISSN: 18734286     Source Type: Journal    
DOI: 10.2174/1381612822666151125001751     Document Type: Review

References (66)

1. Sangwan RS, Chaurasiya ND, Misra LN, et al. Phytochemical variability in commercial herbal products and preparations of Withania somnifera (ashwagandha). Curr Sci 2004; 86: 461-5.
2. Kokate CK, Purohit AP, Gokhale SB. Pharmacognosy 4th ed. India: Nirali Prakashan, Pune 1996; ISBN-978-81-96396-15-2.
3. Nadkararni AK, Nadkarni KM. Indian Materia Medica. Bombay: Prakashan Pvt. Ltd., 1976.
4. Vaidyaratnam PS. Indian Medicinal Plants, A compendium of 500 species. Volume 1, Kottakkal, Arya Vaidya Sala, Coll. No. AVS, 1994; pp 1481.
5. Sharma PV, Vigyan D. Chowkambha Sanskrit Sansthan 1997.
6. Samhita C, Sthana C. Second Chapter, India: Chowkambha Publishers 1997.
7. Suresh Gupta M, Shivaprasad HN, Kharya MD, Rana AC. Immunomodulatory activity of the Ayurvedic formulation of "Ashwagandha churna". Pharm Biol 2006; 44: 263-5.
8. Venkataraghavan S, Seshadri C, Sundaresan TP, Revathi R, Rajagopalan V, Janaki K. The comparative effect of milk fortified with ashwagandha, Aswagandha and punarnava in children-a double blind study. J Res Ayur Sid 1980; 1: 370-85.
9. Handa SS. Plants and plant products for mental health. Decade of the brain. Rockville. MD: US Department of Health and Human Services 1995; pp 163Õ171.
10. Dhuley JN. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother Res 2001; 15: 524-8.
11. Ray AB, Gupta M. Withasteroids, a growing group of naturally occurring steroidal lactones. Prog Chem Org Nat Prod 1994; 63: 2-106.
12. Schliebs R, Liebmann SK, Kumar A, Ghosal S, Bigl V. Systemic administration of de ned extracts from Withania somnifera (Indian ginseng) and Shilajit differentially affects choilinergic but not glutamatergic and GABAergic marker in rat brain. Neuro Chem Int 1973; 30: 181-90.
13. Dhuley JN. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J Ethnopharmacol 2000; 70: 57-63.
14. Singh G, Sharma PK, Dudhe R, Singh S. Biological activities of Withania somnifera. Ann Bioll Res 2010; 1: 56-63.
15. Singh S KVS, S Singhal, Singh N. An indian herbal immunomodulator: Highly effective in the treatment of HIV/AIDS. Proceeding of 6th International Conference AIDS Asian Pacific October 5-10. Melbourn, Australia 2001; pp 5-10.
16. Singh A K, Varsheny R, Sharma M, Agarwal SS, Bansal KC. Regeneration of plants from alginated-encapsulated shoot tips of Withania somnifera (L) Dunal, a medicinally important plant species. J Plant Physiol 2006; 163: 220-223.
17. Rastogi RP. Compendium of Indian Medicinal Plants. India: CSIR 1998.
18. Anon M. Withania somnifera. Altern Med Rev 2004; 9: 211-4.
19. Elsakka M, Grigorescu E, Stanescu U, Dorneanu V. New data referring to chemistry of Withania somnifera species. Rev Med Chir Soc Med Nat Iasi 1990; 94: 385-7.
20. Mwitari PG, Ayeka PA, Ondicho J, Matu EN, Bii GCC. Antimicrobial Activity and Probable Mechanisms of Action of Medicinal Plants of Kenya: Withania somnifera, Warbugia ugandensis, Prunus africana and Plectrunthus barbatus. PLoS One 2013; 8: 9.
21. Owais M, Sharad KS, Shehbaz A, Saleemuddin M. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine 2005; 12: 229-35.
22. Singariya P, Moury KK, Kumar P. Antimicrobial Activity of the Crude Extracts of Withania somnifera and Cenchrus setigerus. Invitro. Phcog J 2012; 4: 60-5.
23. Teixeira ST, Valadares MC, Gonçalves SA, De Melo A, Queiroz MLS. Prophylactic administration of Withania somnifera extract increases host resistance in Listeria monocytogenes infected mice. Int Immunopharmacol 2006; 6: 1535-42.
24. Alam N, Hossain M, Mottalib MA, Sulaiman SA, Gan SH, Khalil MI. Methanolic extracts of Withania somnifera leaves, fruits and roots possess antioxidant properties and antibacterial activities. BMC Complement Alternat Med 2012; 12: 1-8.
25. Arora S, Dhillon S, Rani G, Nagpal A. The in vitro antibacterial/synergistic activities of Withania somnifera extracts. Fitoterapia 2004; 75: 385-8.
26. Kambizi LGBM, Taylor MB, Afolayan AJ. Anti-viral effects of aqueous extracts of Aloe ferox and Withania somnifera on herpes simplex virus type 1 in cell culture. Afr J Sci 2007; 103: 359-60.
27. Kambiz L, Afolayan AJ. Extracts from Aloe ferox and Withania somnifera inhibit Candida albicans and Neisseria gonorrhoea. African J Biotechnol 2008; 7(1).
28. Muralikrishnan G, Dinda AK, Shakeel F. Immunomodulatory effects of Withania somnifera on azoxymethane induced experimental colon cancer in mice. Immunol Invest 2010; 39: 688-98.
29. Muralikrishnan G, Amanullah S, Basha MI, Dinda AK, Shakeel F. Modulating effect of Withania somnifera on TCA cycle enzymes and electron transport chain in azoxymethane-induced colon cancer in mice. Immunopharmacol Immunotoxicol 2010; 32: 523-7.
30. Jayaprakasam B, Zhang Y, Seeram NP, Nair MG. Growth inhibition of human tumor cell lines by withanolides from Withania somnifera leaves. Life Sci 2003; 74: 125-32.
31. Yadav B, Bajaj A, Saxena M, Saxena AK. In vitro anticancer activity of the root, stem and leaves of Withania somnifera against various human cancer cell lines. Indian J Pharm Sci 2010; 72: 659.
32. Singh N, Singh SP, Nath R, et al. Prevention of urethane-induced lung adenomas by Withania somnifera (L.) Dunal in albino mice. Pharm Biol 1986; 24: 90-100.
33. Mary K, Wim VB, Heyerick A, et al. Withaferin a strongly elicits I B kinase hyperphosphorylation concomitant with potent inhibition of its kinase activity. J Biol Chem 2007; 07: 4253-64.
34. Thaiparambil JT, Bender L, Ganesh T, et al. Withaferin A inhibits breast cancer invasion and metastasis at sub-cytotoxic doses by inducing vimentin disassembly and serine 56 phosphorylation. Int J Cancer 2011; 129: 2744-55.
35. Malik F, Kumar A, Bhushan S, et al. Reactive oxygen species generation and mitochondrial dysfunction in the apoptotic cell death of human myeloid leukemia HL-60 cells by a dietary com- pound withaferin A with concomitant protection by N-acetyl cysteine. Apoptosis 2007; 12: 2115-33.
36. Mathur S, Kaur P, Sharma M, et al. The treatment of skin carcinoma, induced by UV B radiation, using 1-oxo-5beta, 6beta-epoxywitha-2-enolide, isolated from the roots of Withania somnifera, in a rat model. Phytomedicine 2004; 11: 452-60.
37. Yang ES, Choi MJ, Kim JH, Choi KS, Kwon TK. Withaferin A enhances radiation-induced apoptosis in Caki cells through induction of reactive oxygen species, Bcl-2 downregulation and Akt inhibition. Chem Biol Interact 2011; 190: 9-15.
38. Yanke Y, Hamza A, Zhang T, et al. Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 2010; 79: 542-51. .
39. Widodo N, Shrestha YG, Ishii T, Kual SC. Selective killing of cancer cells by leaf extracts of Ashwagandha: components, activity, and pathway analyses. Cancer Lett 2008; 262: 37-47.
40. Kuttan G. Use of Withania somnifera Dunal as an adjuvant during radiation therapy. Indian J Exp Biol 1996; 34: 854-6.
41. Aggarwal R, Diwanay S, Patki P. Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol 1999; 97: 27-35.
42. Bani S, Gautam M, Sheikh FA, et al. Selective Th1 up-regulating activity of Withania somnifera aqueous extract in an experimental system using flow cytometry. J Ethnopharmacol 2006; 107: 107-15.
43. Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B. Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol 1996; 50: 69-76.
44. Iuvone T, Esposito G, Capasso F, Izzo AA. Induction of nitric oxide synthase expression by Withania somnifera in macrophages. Life Sci 2003; 72: 1617-25.
45. Siddiqui NA, Sing S, Siddiqui MM, Khan TH. Immunomodulatory effect of Withania somnifera, Asparagus racemose and Picrorhiza kurroa roots. Int J Pharmacol 2012; 8: 108-14.
46. Parihar MS, Hemnani T. Phenolic antioxidants attenuate hippocampal neuronal cell damage against kainic acid induced excitotoxicity. J Biosci 2003; 28: 121-8.
47. Russo A, Izzo A, Cardile V, Borrelli F, Vanella A. Indian medicinal plants as antiradicals and DNA cleavage protectors. Phytomedicine 2001; 8: 125-32.
48. Kumar A, Kulkarni SK. Effect of BR-16A (Mentat), a polyherbal formulation on drug-induced catalepsy in mice. Indian J Exp Biol 2006; 44: 45-8.
49. Ahmad M, Saleem S, Ahmad AS, et al. Neuroprotective effects of Withania somnifera on 6-hydroxydopamine induced Parkinsonism in rats. Hum Exp Toxicol 2005; 24: 137-47.
50. Kuboyama T, Tohda C, Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol 2005; 144: 961-71.
51. Tohda C, Kuboyama T, Komatsu K. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK- N-SH cells. Neuroreport 2000; 11: 1981-5.
52. Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals 2005; 14: 34-45.
53. Vogel HG, Vogel WH, Scholkens BA, Sandow J, Muller G, Vogel W. Pentylenetertazol (metrazol)-induced convulsions. Drug Discov Evalauation 2002.
54. Kulkarni SK, Sharma A, Verma A, Ticku MK. GABA receptor mediated anticonvulsant action of Withania somnifera root extract. Indian Drugs 1993; 30: 305-12.
55. Kulkarni SK, George B. Anticonvulsant action of Withania somnifera (Ashwagandha) root extract against pentylenetetrazol-induced kindling in mice. Phytother Res 1996; 10: 447-9.
56. Choudhary MI, Nawaz SA, Lodhi MA, et al. Withanolides, a new class of natural cholinesterase inhibitors with calcium antagonistic properties. Biochem Biophy Res Commun 2005; 334: 276-87.
57. Jayaprakasam B, Padmanabhan K, Nair MG. Withanamides in Withania somnifera fruit protect PC-12 cells from -amyloid responsible for Alzheimer’s Disease. Phytother Res 2010; 24: 859-63.
58. Archana R, Namasivayam A. Antistressor effect of Withania somnifera. J Ethnopharmacol 1999; 64: 91-3.
59. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolyticantidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine 2000; 7: 463-9.
60. Bhattacharya A, Ghosal S, Bhattacharya SK. Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J. Ethnopharmacol 2001; 74: 1-6.
61. Mehta AK, Binkley P, Gandhi SS, Ticku MK. Pharmacological effects of Withania somnifera root extract on GABAA receptor complex. Indian J Med Res 1991; 94: 312-5.
62. Deepa M, Gowda TV. Purification and characterization of a glyco-protein inhibitor of toxic phospholipase from Withania somnifera. Arch Biochem Biophys 2002; 408: 42-50.
63. Tu AT, Hendon RR. Charecterization of lizard venom hyaluroni-dase and evidence for its action as a spreading factor. Comp Biochem Physiol 1982; 76: 377-83.
64. Machiah DK, Girish KS, Gowda TV. A glycoprotein from a folk medicinal plant, Withania somnifera, inhibits hyaluronidase activity of snake venoms. Comparat Biochem Physiol Part C: Toxicol Pharmacol 2006; 143: 158-61.
65. Girish KS, Machiah KD, Ushanandini S, et al. Antimicrobial properties of a non-toxic glycoprotein (WSG) from Withania somnifera (Ashwagandha). J Basic Microbiol 2006; 46: 365-74.
66. Ghosh M. Purification of a lectin-like antifungal protein from the medicinal herb, Withania somnifera. Fitoterapia 2009; 80: 91-5.